Charles River Laboratories International (CRL) Share-based Compensation (2009 - 2025)

Charles River Laboratories International (CRL) has reported Share-based Compensation for 17 consecutive years, with $17.6 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Share-based Compensation rose 2.3% year-over-year to $17.6 million; the TTM figure through Dec 2025 stood at $71.1 million (up 1.71% YoY), while the FY2025 annual figure was $71.1 million, up 1.71% from the prior year.
• Share-based Compensation came in at $17.6 million for Q4 2025 at Charles River Laboratories International, down from $23.3 million in the prior quarter.
• The five-year high for Share-based Compensation was $23.3 million in Q3 2025, with the low at $13.1 million in Q1 2025.
• Average Share-based Compensation over 5 years is $17.9 million, with a median of $17.2 million recorded in 2021.
• Across the five-year window, Share-based Compensation surged 30.55% in 2021 and slipped 21.53% in 2025, its largest moves.
• Year by year, Share-based Compensation stood at $19.2 million in 2021, then grew by 15.03% to $22.1 million in 2022, then fell by 11.55% to $19.5 million in 2023, then fell by 11.71% to $17.2 million in 2024, then rose by 2.3% to $17.6 million in 2025.
• According to Business Quant data, Share-based Compensation over the past three periods registered $17.6 million, $23.3 million, and $17.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.